Literature DB >> 31794872

Dispersion stability and biocompatibility of four ligand-exchanged NaYF4: Yb, Er upconversion nanoparticles.

Yinghui Chen1, Claudia D'Amario2, Alex Gee3, Hien T T Duong4, Olga Shimoni5, Stella M Valenzuela6.   

Abstract

Surface modification to obtain high dispersion stability and biocompatibility is a key factor for bio-application of upconversion nanoparticles (UCNPs). A systematic study of UCNPs modified with four hydrophilic molecules separately, comparing their dispersion stability in biological buffers and cellular biocompatibility is reported here. The results show that carboxyl-functionalized UCNPs (modified by 3,4-dihydrocinnamic acid (DHCA) or poly(monoacryloxyethyl phosphate (MAEP)) with negative surface charge have superior even-distribution in biological buffers compared to amino-functionalized UCNPs (modified by (aminomethyl)phosphonic (AMPA) or (3-Aminopropyl)triethoxysilane (APTES)) with positive surface charge. Subsequent investigation of cellular interactions revealed high levels of non-targeted cellular uptake of the particles modified with either of the three small molecules (AMPA, APTES, DHCA) and high levels of cytotoxicity when used at high concentrations. The particles were seen to be trapped as particle-aggregates within the cellular cytoplasm, leading to reduced cell viability and cell proliferation, along with dysregulation of the cell cycle as assessed by DNA content measurements. The dramatically reduced proportion of cells in G1 phase and the slightly increased proportion in G2 phase indicates inhibition of M phase, and the appearance of sub-G1 phase reflects cell necrosis. In contrast, MAEP-modified UCNPs are bio-friendly with increased dispersion stability in biological buffers, are non-cytotoxic, with negligible levels of non-specific cellular uptake and no effect on the cell cycle at both low and high concentrations. MAEP-modified UCNPs were further functionalized with streptavidin for intracellular microtubule imaging, and showed clear cytoskeletal structures via their upconversion luminescence. STATEMENT OF SIGNIFICANCE: Upconversion nanoparticles (UCNP) are an exciting potential nanomaterial for bio-applications. Their anti-Stokes luminescence makes them especially attractive to be used as imaging probes and thermal therapeutic reagents. Surface modification is the key to achieving stable and compatible hydrophilic-UCNPs. However, the lack of criteria to assess molecular ligands used for ligand exchange of nanoparticles has hampered the development of surface modification, and further limits UCNP's bio-application. Herein, we report a systematic comparative study of modified-UCNPs with four distinct hydrophilic molecules, assessing each particles' colloidal stability in biological buffers and their cellular biocompatibility. The protocol established here can serve as a potential guide for the surface modification of UCNPs in bio-applications.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bio-imaging; Cell cycle; Cellular uptake; Cytotoxicity; Dispersion stability; Surface modification; Upconversion nanoparticles

Mesh:

Substances:

Year:  2019        PMID: 31794872     DOI: 10.1016/j.actbio.2019.11.048

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  3 in total

1.  Effect of different silica coatings on the toxicity of upconversion nanoparticles on RAW 264.7 macrophage cells.

Authors:  Cynthia Kembuan; Helena Oliveira; Christina Graf
Journal:  Beilstein J Nanotechnol       Date:  2021-01-08       Impact factor: 3.649

Review 2.  The Use of Upconversion Nanoparticles in Prostate Cancer Photodynamic Therapy.

Authors:  Michał Osuchowski; Filip Osuchowski; Wojciech Latos; Aleksandra Kawczyk-Krupka
Journal:  Life (Basel)       Date:  2021-04-19

Review 3.  Upconversion Nanomaterials in Bioimaging and Biosensor Applications and Their Biological Response.

Authors:  Zayakhuu Gerelkhuu; Yong-Ill Lee; Tae Hyun Yoon
Journal:  Nanomaterials (Basel)       Date:  2022-10-04       Impact factor: 5.719

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.